Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
B. Jönsson & G. Karlsson. (1996) Economic Evaluation in Gastrointestinal Disease. Scandinavian Journal of Gastroenterology 31:sup220, pages 44-51.
Read now
Read now
Articles from other publishers (16)
Gisela Kobelt, Alan Thompson, Jenny Berg, Mia Gannedahl & Jennifer Eriksson. (2017) New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis Journal 23:8, pages 1123-1136.
Crossref
Crossref
Yasuhiro Sone, Takashi Kumada, Hidenori Toyoda, Mitsuyoshi Yokoyama, Mototsugu Kato & Masahiro Asaka. (2008)
Eradicating
Helicobacter pylori
in Peptic Ulcer Disease Reduces Medical Costs in the Community
. Helicobacter 13:5, pages 346-351.
Crossref
Crossref
Javier P. Gisbert, Xavier Calvet, Faust Feu, Felipe Bory, Angel Cosme, Pedro Almela, Santos Santolaria, Rosario Aznárez, Manuel Castro, Nuria Fernández, Rafael García-Grávalos, Nuria Cañete, Adolfo Benages, Miguel Montoro, Fernando Borda, Angeles Pérez-Aisa & Jose María Piqué. (2007) Eradication of Helicobacter pylori for the Prevention of Peptic Ulcer Rebleeding. Helicobacter 12:4, pages 279-286.
Crossref
Crossref
Mesut Sancar, Fikret Vehbi Izzettin, Sule Apikoglu-Rabus, Fatih Besisik, Nurdan Tozun & Gul Dulger. (2006) Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. Pharmacy World & Science 28:4, pages 207-214.
Crossref
Crossref
Javier P Gisbert, Sam Khorrami, Fernando Carballo, Xavier Calvet, Emili Gené & Enrique Dominguez-Muñoz. (2004) Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database of Systematic Reviews.
Crossref
Crossref
J. P. Gisbert, S. Khorrami, F. Carballo, X. Calvet, E. Gene & E. Dominguez-Muñoz. (2004) Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Alimentary Pharmacology & Therapeutics 19:6, pages 617-629.
Crossref
Crossref
JP Gisbert, S Khorrami, F Carballo, X Calvet, E Gené & JE Dominguez-Muñoz. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
S. Ikeda, T. Tamamuro, C. Hamashima & M. Asaka. (2001)
Evaluation of the cost-effectiveness of
Helicobacter pylori
eradication triple therapy vs. conventional therapy for ulcers in Japan
. Alimentary Pharmacology & Therapeutics 15:11, pages 1777-1785.
Crossref
Crossref
Rinaldo Pellicano, Sergio Peyre, Nicola Leone, Alessandro Repici, Claudio De Angelis, Roberto Rizzi, Mario Rizzetto & Antonio Ponzetto. (2001) The Effect of the Eradication of Helicobacter pylori Infection on Hemorrhage Because of Duodenal Ulcer. Journal of Clinical Gastroenterology 32:3, pages 222-224.
Crossref
Crossref
Pierluigi Russo, E. Attanasio, O. Leri, F. Fiocca & G. I. Togna. (2013) Analisi costo-efficacia di due combinazioni sequenziali di trattamenti di eradicazione dell’Helicobacter pyloriCost-effectiveness analysis of two protocols of sequential combinations of Helicobacter pylori eradication treatments. PharmacoEconomics Italian Research Articles 3:1, pages 15-25.
Crossref
Crossref
Peter W Groeneveld, Tracy A Lieu, Mark A Fendrick, Leo B Hurley, Lynn M Ackerson, Theodore R Levin & James E Allison. (2001) Quality of Life Measurement Clarifies The Cost-Effectiveness of Helicobacter Pylori Eradication in Peptic Ulcer Disease and Uninvestigated Dyspepsia. American Journal of Gastroenterology 96:2, pages 338-347.
Crossref
Crossref
G. Mathé. (2000) Nonspecific but prognostic Helicobacter pylori and gastric cancer association. Biomedicine & Pharmacotherapy 54:7, pages 359-361.
Crossref
Crossref
Rinaldo PellicanoFranco PalmasVincenzo ArenaBrunello DemarchiNicola LeoneMario RizzettoAntonio Ponzetto. (1999)
Lack of Reinfection after
Helicobacter Pylori
Eradication in Duodenal Ulcer Disease: A Prospective Study from Turin, Italy
. Annals of Saudi Medicine 19:4, pages 376-377.
Crossref
Crossref
Kl GohA Cutler, Abs ChuaRph DingP KandasamiMz MazlamSm Raj. (2009) Optimal treatment for duodenal ulcer disease: A cost–decision analysis in Malaysian patients. Journal of Gastroenterology and Hepatology 14:1, pages 32-38.
Crossref
Crossref
Trevisani, Sartori, Galvani, Ruina, Caselli, Verdianelli & Abbasciano. (1998)
Evaluation of a new ultrashort triple therapy for
Helicobacter pylori
disease
. Alimentary Pharmacology & Therapeutics 12:12, pages 1269-1272.
Crossref
Crossref
Paul Moayyedi & Michael F. Dixon. (1997) Significance of Helicobacter Pylori Infection and Gastric Cancer: Implications for Screening. Gastrointestinal Endoscopy Clinics of North America 7:1, pages 47-64.
Crossref
Crossref